Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Mannose receptor-mediated regulation of serum glycoprotein homeostasis.

Lee SJ, Evers S, Roeder D, Parlow AF, Risteli J, Risteli L, Lee YC, Feizi T, Langen H, Nussenzweig MC.

Science. 2002 Mar 8;295(5561):1898-901.

2.

Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa.

Bures R, Morris L, Williamson C, Ramjee G, Deers M, Fiscus SA, Abdool-Karim S, Montefiori DC.

J Virol. 2002 Mar;76(5):2233-44.

3.

Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR.

Feinberg H, Mitchell DA, Drickamer K, Weis WI.

Science. 2001 Dec 7;294(5549):2163-6.

4.

DC-SIGN and DC-SIGNR: helping hands for HIV.

Pöhlmann S, Baribaud F, Doms RW.

Trends Immunol. 2001 Dec;22(12):643-6. No abstract available.

PMID:
11738974
7.

The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission.

Baribaud F, Pöhlmann S, Doms RW.

Virology. 2001 Jul 20;286(1):1-6. Review. No abstract available.

8.

Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.

Moore JP, Parren PW, Burton DR.

J Virol. 2001 Jul;75(13):5721-9. Review. No abstract available.

9.
10.

Directing the immune response to carbohydrate antigens.

Cunto-Amesty G, Dam TK, Luo P, Monzavi-Karbassi B, Brewer CF, Van Cott TC, Kieber-Emmons T.

J Biol Chem. 2001 Aug 10;276(32):30490-8. Epub 2001 May 30. Erratum in: J Biol Chem 2001 Nov 2;276(44):41526.

11.

The antiviral activity of antibodies in vitro and in vivo.

Parren PW, Burton DR.

Adv Immunol. 2001;77:195-262. Review. No abstract available.

PMID:
11293117
12.

Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice.

Kudryashov V, Glunz PW, Williams LJ, Hintermann S, Danishefsky SJ, Lloyd KO.

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3264-9.

13.

gp120: Biologic aspects of structural features.

Poignard P, Saphire EO, Parren PW, Burton DR.

Annu Rev Immunol. 2001;19:253-74.

PMID:
11244037
14.

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates.

Kwong PD, Wyatt R, Majeed S, Robinson J, Sweet RW, Sodroski J, Hendrickson WA.

Structure. 2000 Dec 15;8(12):1329-39. Erratum in: Structure Fold Des 2001 Feb 7;9(2):following R32.

PMID:
11188697
15.
16.

Expression, purification, and characterization of gp160e, the soluble, trimeric ectodomain of the simian immunodeficiency virus envelope glycoprotein, gp160.

Chen B, Zhou G, Kim M, Chishti Y, Hussey RE, Ely B, Skehel JJ, Reinherz EL, Harrison SC, Wiley DC.

J Biol Chem. 2000 Nov 10;275(45):34946-53.

17.

Energetics of the HIV gp120-CD4 binding reaction.

Myszka DG, Sweet RW, Hensley P, Brigham-Burke M, Kwong PD, Hendrickson WA, Wyatt R, Sodroski J, Doyle ML.

Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9026-31.

18.

The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.

Parren PW, Moore JP, Burton DR, Sattentau QJ.

AIDS. 1999;13 Suppl A:S137-62. Review. No abstract available.

PMID:
10885772
20.

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.

Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y.

Cell. 2000 Mar 3;100(5):587-97.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk